CN108991500A - A kind of tumour patient full nutrition formula food - Google Patents
A kind of tumour patient full nutrition formula food Download PDFInfo
- Publication number
- CN108991500A CN108991500A CN201810708141.7A CN201810708141A CN108991500A CN 108991500 A CN108991500 A CN 108991500A CN 201810708141 A CN201810708141 A CN 201810708141A CN 108991500 A CN108991500 A CN 108991500A
- Authority
- CN
- China
- Prior art keywords
- tumour patient
- vitamin
- full nutrition
- protein
- formula food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 77
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 48
- 230000035764 nutrition Effects 0.000 title claims abstract description 42
- 235000013305 food Nutrition 0.000 title claims abstract description 31
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 26
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 26
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 12
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 11
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 9
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims abstract description 8
- 229960004203 carnitine Drugs 0.000 claims abstract description 8
- 229960001231 choline Drugs 0.000 claims abstract description 8
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 8
- 239000011707 mineral Substances 0.000 claims abstract description 8
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 7
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 5
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 239000000419 plant extract Substances 0.000 claims abstract description 4
- 235000018102 proteins Nutrition 0.000 claims description 25
- 239000011669 selenium Substances 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 12
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 11
- 229910052711 selenium Inorganic materials 0.000 claims description 11
- 235000019197 fats Nutrition 0.000 claims description 10
- 235000014633 carbohydrates Nutrition 0.000 claims description 9
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 8
- 235000013734 beta-carotene Nutrition 0.000 claims description 8
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 8
- 239000011648 beta-carotene Substances 0.000 claims description 8
- 229960002747 betacarotene Drugs 0.000 claims description 8
- 230000035622 drinking Effects 0.000 claims description 8
- 235000008216 herbs Nutrition 0.000 claims description 8
- 230000010354 integration Effects 0.000 claims description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 7
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 7
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- 229930003316 Vitamin D Natural products 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- 229930003448 Vitamin K Natural products 0.000 claims description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 229910052804 chromium Inorganic materials 0.000 claims description 7
- 239000011651 chromium Substances 0.000 claims description 7
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 7
- 229960000304 folic acid Drugs 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011724 folic acid Substances 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 229960000310 isoleucine Drugs 0.000 claims description 7
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 7
- 239000011777 magnesium Substances 0.000 claims description 7
- 229910052749 magnesium Inorganic materials 0.000 claims description 7
- 229910052750 molybdenum Inorganic materials 0.000 claims description 7
- 239000011733 molybdenum Substances 0.000 claims description 7
- 235000001968 nicotinic acid Nutrition 0.000 claims description 7
- 229960003512 nicotinic acid Drugs 0.000 claims description 7
- 239000011664 nicotinic acid Substances 0.000 claims description 7
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- 239000011574 phosphorus Substances 0.000 claims description 7
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 7
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- 239000011691 vitamin B1 Substances 0.000 claims description 7
- 239000011715 vitamin B12 Substances 0.000 claims description 7
- 239000011726 vitamin B6 Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 235000019166 vitamin D Nutrition 0.000 claims description 7
- 239000011710 vitamin D Substances 0.000 claims description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 235000019168 vitamin K Nutrition 0.000 claims description 7
- 239000011712 vitamin K Substances 0.000 claims description 7
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 229940046008 vitamin d Drugs 0.000 claims description 7
- 229940046010 vitamin k Drugs 0.000 claims description 7
- 239000011701 zinc Substances 0.000 claims description 7
- 229910052725 zinc Inorganic materials 0.000 claims description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical group CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 6
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 6
- 239000004474 valine Substances 0.000 claims description 6
- 229940024606 amino acid Drugs 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 239000008158 vegetable oil Substances 0.000 claims description 5
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- 108010073771 Soybean Proteins Proteins 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 244000098338 Triticum aestivum Species 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 4
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 229940124277 aminobutyric acid Drugs 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- 102000011632 Caseins Human genes 0.000 claims description 2
- 108010076119 Caseins Proteins 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 244000179886 Moringa oleifera Species 0.000 claims description 2
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 2
- 240000004371 Panax ginseng Species 0.000 claims description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 235000004347 Perilla Nutrition 0.000 claims description 2
- 244000124853 Perilla frutescens Species 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- 244000197580 Poria cocos Species 0.000 claims description 2
- 235000008599 Poria cocos Nutrition 0.000 claims description 2
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- 229920000294 Resistant starch Polymers 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 235000021120 animal protein Nutrition 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- -1 oligoisomaltose Polymers 0.000 claims description 2
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 239000010773 plant oil Substances 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- 235000021254 resistant starch Nutrition 0.000 claims description 2
- 229940001941 soy protein Drugs 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 240000008397 Ganoderma lucidum Species 0.000 claims 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims 1
- 235000002710 Ilex cornuta Nutrition 0.000 claims 1
- 241001310146 Ilex cornuta Species 0.000 claims 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims 1
- 244000126002 Ziziphus vulgaris Species 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 abstract description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 6
- 230000036506 anxiety Effects 0.000 abstract description 6
- 206010067268 Post procedural infection Diseases 0.000 abstract description 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 3
- 230000029663 wound healing Effects 0.000 abstract description 3
- 206010058046 Post procedural complication Diseases 0.000 abstract description 2
- 208000035965 Postoperative Complications Diseases 0.000 abstract description 2
- 230000002503 metabolic effect Effects 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229910052748 manganese Inorganic materials 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 239000011716 vitamin B2 Substances 0.000 description 4
- 102000036675 Myoglobin Human genes 0.000 description 3
- 108010062374 Myoglobin Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 2
- 102000008934 Muscle Proteins Human genes 0.000 description 2
- 108010074084 Muscle Proteins Proteins 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000002313 intestinal cancer Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 235000011609 Pinus massoniana Nutrition 0.000 description 1
- 241000018650 Pinus massoniana Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 241000254223 Syntexis Species 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 229940038481 bee pollen Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004140 ketosis Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 208000015768 polyposis Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 208000020615 rectal carcinoma Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention provides a kind of tumour patient full nutrition formula food, it is characterised in that is matched by following substance: predigestion carbohydrate;Compound protein;Compound fat;γ-aminobutyric acid;Dietary fiber;Plant extracts;Mineral substance premix;Vitamin premix;Choline carnitine;Se-enriched yeast powder;5 '-the sapidity nucleotide disodiums.Tumour patient of the invention is with full nutrition formula food for the demand of the psychological pressure of the nutritional support of tumour patient, nutrition treatment and alleviation tumour patient, combine the metabolic characteristic of tumor disease, a kind of full nutrition formula product of tumour patient is provided, to mitigate the stress such as frightened tumour patient, anxiety and melancholy, improve malnutritive situation, improve low albumen, correct negative nitrogen balance, reduce postoperative infection and complication, accelerating wound healing, improve tumour patient quality of life, extends life span.
Description
Technical field
The present invention relates to special medicine purposes to be formulated wholefood, matches more particularly to a kind of full nutrition of tumour patient
Square food.
Background technique
Tumour is a kind of chronic disease, it is reported that tumour patient more than 300 ten thousand is newly sent out in China every year, wherein one third is pernicious
Tumour, about 90% malignant tumour need to carry out radiotherapy, chemotherapy during entire treatment.Tumor operation treatment and chemotherapy pair
The damage of patient body nutrition condition is larger, has different degrees of protein to lack more.Usually protein conversion ratio increases in patient body
Add, hepatic protein synthesis increase, and muscle protein synthesis reduces.Muscle protein breakdown makes patient's syntexis, weight loss, is immunized
Power reduces.China's malignant tumor patient treatment phase mean survival time less than developed country one third, and it is malnutritive, dislike
Sick matter and its caused treatment failure and related complication are exactly the immediate cause of most tumors patient's death.
Clinic nutrition treatment is to alleviate tumour patient metabolic disorder, intervene malnutritive, sluggish cachexia process, mitigate and control
Treat the important means of related toxic side effect.However, China obtains the malignant tumor patient of positive nutrition treatment less than 10% every year,
, main reason is that domestic clinical tumor nutrition product is deficient, nutrition treatment consciousness is weak for it.
In addition, the stress of tumour patient is also very important, tumour patient nearly all has mental handicape, with medicine section
Progress, tumour case fatality rate has a degree of decline at present, but tumour is obstinate disease after all, thus fears to tumour
Fear psychology to be widely present.Appearance adverse reaction especially in therapeutic process, then aggravate the emotional handicaps such as anxiety, depression,
It is mainly shown as: the feared state of mind, Mental Depression and anxious psychology, and serious mental handicape is also unfavorable for the product of tumour patient
Pole treatment.
For mental handicape other than psychological counseling, nutritional intervention is also one of important means, however, current tumour is sought
Feeding product only carries out nutritional support to tumour patient from simple nutritional point, can not play and adjust patient's mood, mitigates disease
The effect of human psychological's pressure.
Summary of the invention
The present invention for the nutritional support of tumour patient, nutrition treatment and alleviate tumour patient psychological pressure demand,
The metabolic characteristic for combining tumor disease provides a kind of full nutrition formula product of tumour patient, frightened, burnt to mitigate tumour patient
Consider and the stress such as melancholy, improve malnutritive situation, improve low albumen, correct negative nitrogen balance, reduces postoperative infection and simultaneously
Disease is sent out, accelerating wound healing improves tumour patient quality of life, extends life span.
A kind of tumour patient full nutrition formula food provided by the invention, which is characterized in that by following mass percent
Substance be prepared:
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where above-mentioned predigestion carbohydrate is by the rice meal of extruding or enzymolysis processing, corn flour, oatmeal, wheat
One or more of powder, maltodextrin, enzymatic hydrolysis rice flour, malt extract.
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where above-mentioned compound protein is made of albumen and protein peptides, and above-mentioned albumen is selected from one of vegetable protein or animal protein
Or it is several;
Above-mentioned albumen by one of soybean protein, rice protein, lactalbumin, casein, collagen, milk powder or
Several compositions;
Above-mentioned protein peptides are by Soyprotein peptide, whey protein peptide, wheat protein peptide, collagen peptide, ovalbumin peptide
One or more of compositions.
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where above-mentioned amino acid is made of one or more of glutamine, arginine, branched-chain amino acid;
Above-mentioned branched-chain amino acid is made of leucine, isoleucine and valine, leucine: isoleucine: figured silk fabrics ammonia
The mass ratio of acid is 1.5~2.5:0.5~1.5:0.5~1.5;
Preferably, leucine: isoleucine: the mass ratio of valine is 1.8~2.2:0.8~1.2:0.8~1.2, bright
Propylhomoserin: isoleucine: the optimum quality ratio of valine is 2:1:1
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where above-mentioned compound fat is made of vegetable oil, medium chain triglyceride, omega-3 unsaturated fatty acid and conjugated linoleic acid;
Above-mentioned composite plant oil is selected from corn oil, tea-seed oil, sunflower oil, rapeseed oil, peanut oil, soybean oil, purple perilla
One or more of oil, linseed oil.
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where above-mentioned dietary fiber is by resistant starch, resistant dextrin, oligoisomaltose, polydextrose, chitosan oligosaccharide, oligomeric fruit
One or more of sugar, inulin, soybean polyoses composition.
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where above-mentioned mineral substance premix is selected from containing one in sodium, potassium, calcium, phosphorus, magnesium, iron, iodine, copper, zinc, manganese, selenium, molybdenum, chromium
Kind is several.
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where said vitamin premix, which is selected from, contains vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin B12, vitamin C, niacin, folic acid, pantothenic acid, biotin, taurine, one of beta carotene
Or it is several.
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where be made of in above-mentioned plant extracts broken pollen and integration of drinking and medicinal herbs living resources;
Above-mentioned broken pollen is selected from one of the pollen pini of ultralow temperature physical wall breaking, Bee Pollen or two kinds;
Above-mentioned integration of drinking and medicinal herbs living resources are selected from jujube, Poria cocos, rhizoma polygonati, pollen pini, mushroom, ginseng, ginger, Moringa, spirit
One or more of sesame, fructus lycii, rde bean, Chinese yam, sea-buckthorn, dried orange peel.
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign: where above-mentioned γ-aminobutyric acid is the food-grade γ-aminobutyric acid produced with biological fermentation process.
Further, in tumour patient full nutrition formula food provided by the invention, there can also be such spy
Sign, is prepared by the substance of following mass percent:
The action and effect of invention
Tumour patient of the invention can provide required energy with full nutrition formula food for tumour patient, provide various
Nutrient and microelement, and help to mitigate the stress such as frightened tumour patient, anxiety and melancholy, improve patient's nutrition
Undesirable condition improves low albumen, corrects negative nitrogen balance, reduces postoperative infection and complication, and accelerating wound healing improves neoplastic disease
Living quality of patients extends its life span.
γ~aminobutyric acid, this naturally occurring nonprotein functionality amino are added in product formula of the invention
Acid can obstruct information relevant to anxiety and arrive at brain instruction maincenter, and the adjusting to people's autonomic nerve slows down anxiety, to reach anti-
Pressure, effect antianxity alleviate patient to the anxiety of tumour, preferably partner treatment.In addition, γ~aminobutyric acid plays improvement
Patient's sleep;Brain vigor, the supply for increasing oxygen, the metabolism for promoting brain are improved, function of brain cell is restored;Trophic nerve is thin
The effects of born of the same parents, raising immunity.
It include predigestion carbohydrate in product formula of the invention, this kind of carbon by by extruding or enzymolysis processing
Hydrate is more easier to be absorbed by patient.
It include compound protein in product formula of the invention, the characteristics of shortage for tumour patient protein, compound protein
It is made of albumen, protein peptides and amino acid, such compound protein is easier to be absorbed by the body, and facilitates human tissue cell
It repairs, facilitates the case where improving tumour patient low albumen.Branched-chain amino acid by the leucine of proper proportion, isoleucine and
Valine composition, can effectively prevent muscle loss, help to repair muscle, control blood glucose, and provide energy to bodily tissue.
In product formula of the invention compound fat by vegetable oil, medium chain triglyceride, omega-3 unsaturated fatty acid and
Conjugated linoleic acid forms, and a variety of unsaturated fatty acids are contained in vegetable oil, are easier to be absorbed by the body;Medium chain triglyceride provides more
For the contact interface of enzyme effect, so that it is absorbed fast and abundant, Metabolism of Apolipoprotein can be improved, oxidation is complete rapidly, makes to swell
Tumor patient, which is in ketosis state, can inhibit the glucose metabolism and growth of knurl, while maintain the nutritional status of patient;ω -3 is not
Saturated fatty acid is beneficial to prevent and treat coronary heart disease, diabetes, rheumatoid, cancer, psychotic disorder, depression, nephrosis etc.
A variety of diseases help to maintain body fat mass in human body acid balance;Conjugated linoleic acid helps to enhance the oxidation resistance of human body and exempt from
Epidemic disease ability, can dramatically increase human body myocardial myoglobin and conjugated linoleic acid promotes fat oxidation to decompose, and human body protein is promoted to close
At increasing myocardial myoglobin, the skeletal muscle myoglobin content of human body, it is (white to adjust tumor necrosis factor-Α, cell factor
Cytokine Isosorbide-5-Nitrae, 6,8), while reducing allergic immune response.
Broken pollen and integration of drinking and medicinal herbs living resources are added in product formula of the invention.Broken masson pine pollen contains human body
200 required various nutrient elements have anti-aging, prevent hepatopathy, and can promote liver detoxification function, can repair kidney
The tissue of damage, prevents cancer cell development, promotes fat and protein eubolism and other effects, it helps adjustment body
Function, mood can be stabilized, make patient be not easy to get angry, is in high spirits.Broker wall bee pollen helps to enhance physical strength, improves nerve carefully
The function of born of the same parents, antibacterial, anti-aging, maintains bone health, a variety of diseases such as prevention intestinal cancer, cardiovascular disease at enhancing immune function.
And the pollen of ultralow temperature wall breaking technology processing has been fully retained that whole nutritions, granularity that pollen includes are superfine, and diameter is only
There are 3 microns, human absorptivity is up to 99%.Integration of drinking and medicinal herbs living resources play the role of nutritional supplementation and efficacy of drugs.In this product
Addition broken pollen and integration of drinking and medicinal herbs living resources help to improve tumour patient quality of life, extend life span.
Se-enriched yeast powder is added in product formula of the invention, trace elements of selenium is to liver cancer, breast cancer, oophoroma, stomach
The kinds of tumors such as cancer, colon and rectum carcinoma, prostate cancer, lung cancer have significant preventive and therapeutic action, and the hair of tumour
Life, development are also related with the insufficiency of intake of selenium, and selenium-supply helps to adjust the immune function of human body, improve human body cancer-resisting comprehensively
Ability.This organism organic selenium of Se-enriched yeast powder is added, enables that selenium is more efficient, be more safely absorbed by the body utilization.
It is added to dietary fiber in product formula of the invention, there is very important work in dietary fiber digestive system
With, it helps a variety of diseases such as prevention diabetes, hyperlipidemia, intestinal cancer, constipation, polyposis intestinalis.It also added in formula more
Minerals and vitamins are planted, is to maintain health institute necessary material, boosts metabolism, bring beneficial functional to human body, than
If beta carotene have detoxication, anticancer, prevention cardiovascular disease, cataract and it is anti-oxidant on have significant function, and
And then prevent a variety of degenerative disorders caused by aging and aging.
Addition choline carnitine helps to reduce the triglyceride and cholesterol levels in blood, inhibits depressive symptoms.Add
Add 5 '-the sapidity nucleotide disodiums to help to enhance and improve flavour of food products, so that product is in good taste, be easy to be received by patient,
Blood circulation is peomoted, is boosted metabolism, system is enhanced, improves immunity.
Each component using special ratios cooperation addition, is guaranteed product by tumour patient full nutrition formula food of the invention
The effect of finished product, alleviates the stress of tumour patient, more while providing nutritional support, nutrition treatment for tumour patient
The deficiency of tumour patient full nutrition formula food in clinic is mended.
Specific embodiment
Tumour patient of the invention is specifically addressed with full nutrition formula food for following embodiments, following embodiments
For preferred case of the invention, the protection scope being not intended to limit the invention.It is sought in the tumour patient of following embodiments with complete
It supports in formula, branched-chain amino acid is made of leucine, isoleucine and valine, leucine: isoleucine: the matter of valine
Amount is than being 2:1:1.Mineral substance premix is containing sodium, potassium, calcium, phosphorus, magnesium, iron, iodine, copper, zinc, manganese, selenium, molybdenum, chromium mixture
Mineral substance premix;Vitamin premix is to contain vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin B12, vitamin C, niacin, folic acid, pantothenic acid, biotin, taurine, beta carotene mixture
Vitamin premix.Broken pollen be under subzero 170 DEG C of condition of ultralow temperature one of pollen pini of physical wall breaking, Bee Pollen or
Two kinds.γ-aminobutyric acid is the food-grade γ-aminobutyric acid of biological fermentation process production.
<implementing 1>
The tumour patient of embodiment 1 is made of with full nutrient formulation the raw material of following mass percent:
Nutrient component meter
Project | Every 100g | NRV% | Project | Every 100g | NRV% |
Energy | 1925kJ(460kcal) | 22% | Vitamin C | 60.0mg | 60% |
Protein | 19.5g | 34% | Niacin | 9.08mg | 64.5% |
Fat | 16.0g | 27% | Folic acid | 240μgDFE | 60% |
Carbohydrate | 54.5g | 17% | Biotin | 15.0μg | 49.5% |
... polysaccharide | 1.5g | Choline | 150.0mg | 33% | |
Dietary fiber | 5.0g | 20% | Phosphorus | 240mg | 34.5% |
Sodium | 600mg | 30% | Potassium | 600mg | 30% |
Vitamin A | 382.5μgRE | 48% | Magnesium | 130.5mg | 43.5% |
... beta carotene | 90 μ gRE (in terms of VA) | Calcium | 360mg | 45% | |
Cyclic adenosine monophosphate | 300ppm | Iron | 6.0mg | 40.5% | |
Vitamin D | 3.0μg | 60% | Zinc | 6.15mg | 40.5% |
Vitamin E | 15.11mgα-TE | 108% | Selenium | 25.0μg | 50% |
Vitamin K | 45.0μg | 57% | Manganese | 0.56mg | 18% |
Vitamin B1 | 0.90mg | 64.5% | Chromium | 18μg | |
Vitamin B2 | 0.90mg | 64.5% | Molybdenum | 28.5μg | |
Vitamin B6 | 0.90mg | 64.5% | Carnitine | 45.0mg | |
Vitamin B12 | 1.58μg | 66% |
<implementing 2>
The tumour patient of embodiment 2 is made of with full nutrient formulation the raw material of following mass percent:
Nutrient component meter
Project | Every 100g | NRV% | Project | Every 100g | NRV% |
Energy | 1933kJ(462kcal) | 24% | Vitamin C | 40.0mg | 40% |
Protein | 25.5g | 43% | Niacin | 6.05mg | 43% |
Fat | 18.0g | 30% | Folic acid | 160μgDFE | 40% |
Carbohydrate | 46.5g | 15% | Biotin | 10.0μg | 33% |
... polysaccharide | 2.0g | Choline | 100.0mg | 22% | |
Dietary fiber | 6.0g | 24% | Phosphorus | 160mg | 23% |
Sodium | 400mg | 20% | Potassium | 400mg | 20% |
Vitamin A | 255μgRE | 32% | Magnesium | 87mg | 29% |
... beta carotene | 60 μ gRE (in terms of VA) | Calcium | 240mg | 30% | |
Cyclic adenosine monophosphate | 600ppm | Iron | 4.0mg | 27% | |
Vitamin D | 2.0μg | 40% | Zinc | 4.10mg | 27% |
Vitamin E | 10.08mgα-TE | 72% | Selenium | 25.0μg | 100% |
Vitamin K | 30.0μg | 38% | Manganese | 0.37mg | 12% |
Vitamin B1 | 0.60mg | 43% | Chromium | 12μg | |
Vitamin B2 | 0.60mg | 43% | Molybdenum | 19μg | |
Vitamin B6 | 0.60mg | 43% | Carnitine | 30.0mg | |
Vitamin B12 | 1.05μg | 44% |
<implementing 3>
The tumour patient of embodiment 3 is made of with full nutrient formulation the raw material of following mass percent:
Nutrient component meter
Project | Every 100g | NRV% | Project | Every 100g | NRV% |
Energy | 2008kJ(480kcal) | 22% | Vitamin C | 80.0mg | 80% |
Protein | 23.5g | 39% | Niacin | 12.10mg | 86% |
Fat | 22.0g | 36% | Folic acid | 320μgDFE | 80% |
Carbohydrate | 45.5g | 17% | Biotin | 20.0μg | 66% |
... polysaccharide | 1.0g | Choline | 200.0mg | 44% | |
Dietary fiber | 3.0g | 24% | Phosphorus | 320mg | 46% |
Sodium | 800mg | 40% | Potassium | 800mg | 40% |
Vitamin A | 510μgRE | 64% | Magnesium | 174mg | 58% |
... beta carotene | 120 μ gRE (in terms of VA) | Calcium | 480mg | 60% | |
Vitamin D | 4.0μg | 80% | Iron | 8.0mg | 54% |
Vitamin E | 40.30mgα-TE | 144% | Zinc | 8.20mg | 54% |
Vitamin K | 60.0μg | 76% | Selenium | 200.0μg | 400% |
Vitamin B1 | 1.20mg | 86% | Manganese | 0.74mg | 24% |
Vitamin B2 | 1.20mg | 86% | Chromium | 24μg | |
Vitamin B6 | 1.20mg | 86% | Molybdenum | 38μg | |
Vitamin B12 | 2.10μg | 88% | Carnitine | 60.0mg |
<implementing 4>
The tumour patient of embodiment 4 is made of with full nutrient formulation the raw material of following mass percent:
Nutrient component meter
Project | Every 100g | NRV% | Project | Every 100g | NRV% |
Energy | 1849kJ(442kcal) | 22% | Vitamin C | 40.0mg | 40% |
Protein | 21.5g | 36% | Niacin | 6.05mg | 43% |
Fat | 14.0g | 23% | Folic acid | 160μgDFE | 40% |
Carbohydrate | 54.5g | 17% | Biotin | 10.0μg | 33% |
... polysaccharide | 2.0g | Choline | 100.0mg | 22% | |
Dietary fiber | 6.0g | 24% | Phosphorus | 160mg | 23% |
Sodium | 400mg | 20% | Potassium | 400mg | 20% |
Vitamin A | 255μgRE | 32% | Magnesium | 87mg | 29% |
... beta carotene | 60 μ gRE (in terms of VA) | Calcium | 240mg | 30% | |
Vitamin D | 2.0μg | 40% | Iron | 4.0mg | 27% |
Vitamin E | 10.08mgα-TE | 72% | Zinc | 4.10mg | 27% |
Vitamin K | 30.0μg | 38% | Selenium | 100.0μg | 200% |
Vitamin B1 | 0.60mg | 43% | Manganese | 0.37mg | 12% |
Vitamin B2 | 0.60mg | 43% | Chromium | 12μg | |
Vitamin B6 | 0.60mg | 43% | Molybdenum | 19μg | |
Vitamin B12 | 1.05μg | 44% | Carnitine | 30.0mg |
Claims (10)
1. a kind of tumour patient full nutrition formula food, which is characterized in that be prepared by the substance of following mass percent:
Predigestion carbohydrate 1~75%
Compound protein 1~65%
Compound fat 1~45%
γ-aminobutyric acid 0.1~5%
Dietary fiber 0.5~20%
Plant extracts 1~35%
Mineral substance premix 0.5~15%
Vitamin premix 0.1~10%
Choline carnitine 0.1~10%
Se-enriched yeast powder 0.01~3%
5 '-the sapidity nucleotide disodiums 0.01~3%.
2. tumour patient full nutrition formula food according to claim 1, it is characterised in that:
Wherein, the predigestion carbohydrate is by the rice meal of extruding or enzymolysis processing, corn flour, oatmeal, wheat
One or more of powder, maltodextrin, enzymatic hydrolysis rice flour, malt extract.
3. tumour patient full nutrition formula food according to claim 1, it is characterised in that:
Wherein, the compound protein is made of albumen, protein peptides and amino acid,
The albumen is selected from one or more of vegetable protein or animal protein,
The albumen is by one or more of soybean protein, rice protein, lactalbumin, casein, collagen, milk powder group
At,
The protein peptides are by one of Soyprotein peptide, whey protein peptide, wheat protein peptide, collagen peptide, ovalbumin peptide
Or several compositions.
4. tumour patient full nutrition formula food according to claim 3, it is characterised in that:
Wherein, the amino acid is made of one or more of glutamine, arginine, branched-chain amino acid,
The branched-chain amino acid is made of leucine, isoleucine and valine, leucine: isoleucine: the matter of valine
Amount ratio is 1.5~2.5:0.5~1.5:0.5~1.5,
Preferably, leucine: isoleucine: the mass ratio of valine is 1.8~2.2:0.8~1.2:0.8~1.2.
5. tumour patient full nutrition formula food according to claim 1, it is characterised in that:
Wherein, the compound fat is by vegetable oil, medium chain triglyceride, omega-3 unsaturated fatty acid and conjugated linoleic acid group
At,
The composite plant oil is selected from corn oil, tea-seed oil, sunflower oil, rapeseed oil, peanut oil, soybean oil, perilla herb oil, Asia
One or more of flaxseed oil.
6. tumour patient full nutrition formula food according to claim 1, it is characterised in that:
Wherein, the dietary fiber is by resistant starch, resistant dextrin, oligoisomaltose, polydextrose, chitosan oligosaccharide, oligomeric
One or more of fructose, inulin, soybean polyoses composition.
7. tumour patient full nutrition formula food according to claim 1, it is characterised in that:
Wherein, the mineral substance premix is selected from containing one in sodium, potassium, calcium, phosphorus, magnesium, iron, iodine, copper, zinc, manganese, selenium, molybdenum, chromium
Kind is several.
8. tumour patient full nutrition formula food according to claim 1, it is characterised in that:
Wherein, the vitamin premix, which is selected from, contains vitamin A, vitamin D, vitamin E, vitamin K, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin B12, vitamin C, niacin, folic acid, pantothenic acid, biotin, taurine, one of beta carotene
Or it is several.
9. tumour patient full nutrition formula food according to claim 1, it is characterised in that:
Wherein, it is made of in the plant extracts broken pollen and integration of drinking and medicinal herbs living resources,
The broken pollen is selected from one of the pollen pini of ultralow temperature physical wall breaking, Bee Pollen or two kinds,
The integration of drinking and medicinal herbs living resources are selected from jujube, Poria cocos, rhizoma polygonati, pollen pini, mushroom, ginseng, ginger, Moringa, ganoderma lucidum, Chinese holly
One or more of Qi, rde bean, Chinese yam, sea-buckthorn, dried orange peel.
10. tumour patient full nutrition formula food described according to claim 1~any one of 9, which is characterized in that by
The substance of following mass percent is prepared:
Predigestion carbohydrate 5~65%
Albumen 5~35%
Protein peptides 3~25%
Amino acid 1~15%
γ~aminobutyric acid 0.1~1%
Vegetable oil 5~25%
Medium chain triglyceride 2~22%
The unsaturated fatty acid of ω~3 1~10%
Conjugated linoleic acid 0.2~3%
Dietary fiber 0.5~10%
Integration of drinking and medicinal herbs living resources 2~25%
Broken pollen 0.5~10%
Mineral substance premix 0.5~10%
Vitamin premix 0.1~5%
Choline carnitine 0.1~5%
Se-enriched yeast powder 0.01~1%
5 '-the sapidity nucleotide disodiums 0.01~1%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810708141.7A CN108991500A (en) | 2018-07-02 | 2018-07-02 | A kind of tumour patient full nutrition formula food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810708141.7A CN108991500A (en) | 2018-07-02 | 2018-07-02 | A kind of tumour patient full nutrition formula food |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108991500A true CN108991500A (en) | 2018-12-14 |
Family
ID=64598690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810708141.7A Pending CN108991500A (en) | 2018-07-02 | 2018-07-02 | A kind of tumour patient full nutrition formula food |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108991500A (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109645484A (en) * | 2019-02-27 | 2019-04-19 | 王启荣 | A kind of nutritional formulas for senile chronic disease |
CN109805389A (en) * | 2019-02-26 | 2019-05-28 | 青岛大学附属医院 | A kind of tumour tailored version clinical nutrition formula and preparation method thereof |
CN110150654A (en) * | 2019-06-21 | 2019-08-23 | 上海中优精准医疗科技股份有限公司 | A kind of special medicine purposes formula food for tumor patient |
CN110179107A (en) * | 2019-07-01 | 2019-08-30 | 北京东方倍力营养科技有限公司 | A kind of complete nutritional composition improving liver function and liver fibrosis |
CN110301629A (en) * | 2019-07-03 | 2019-10-08 | 安亦臣(武汉)健康科技有限公司 | A kind of full nutrient solid beverage of tumor patient and preparation method thereof |
CN110419727A (en) * | 2019-09-03 | 2019-11-08 | 生生源(大连)科技有限公司 | It effectively can prevent and improve the natural mineral matter replenishers of tumour |
CN110419728A (en) * | 2019-09-09 | 2019-11-08 | 山东禹泽医药科技有限公司 | A kind of tumour patient special medicine purposes full nutrition formula food |
CN110839803A (en) * | 2019-09-09 | 2020-02-28 | 付艳霞 | Total-nutrient meal replacement composition for treating tumor anorexia |
CN110916195A (en) * | 2019-11-25 | 2020-03-27 | 中国海洋大学 | Total nutrient tumor formula food added with specific marine oligopeptide and preparation method thereof |
CN112089051A (en) * | 2019-12-04 | 2020-12-18 | 上海张新生物医药科技有限公司 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
CN112167614A (en) * | 2020-10-27 | 2021-01-05 | 袁希福 | A dietetic composition for postoperative treatment of tumor patients and radiotherapy and chemotherapy patients, and its preparation method |
CN113694179A (en) * | 2021-08-20 | 2021-11-26 | 安徽国肽生物科技有限公司 | Preparation method and application of ternary polypeptide nanoparticles based on yak bone peptide |
CN114868890A (en) * | 2022-03-26 | 2022-08-09 | 大医声科技(北京)有限公司 | Multi-vitamin nutrient formula suitable for tumor patients |
CN113694179B (en) * | 2021-08-20 | 2024-05-10 | 安徽国肽生物科技有限公司 | Preparation method and application of ternary polypeptide nano-particles based on yak bone peptide |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101971939A (en) * | 2010-06-23 | 2011-02-16 | 安徽万山生物科技有限公司 | Process for making bee pollen freeze-dried powder through low-temperature high-pressure wall-breaking |
CN101971940A (en) * | 2010-06-23 | 2011-02-16 | 安徽万山生物科技有限公司 | Process for preparing low-temperature high-pressure wall-breaking pine pollen frozen powder capsule |
CN102526698A (en) * | 2012-01-05 | 2012-07-04 | 苟春虎 | Cordyceps polypeptide amino acid nutrient solution |
CN103330215A (en) * | 2013-07-11 | 2013-10-02 | 西安力邦临床营养有限公司 | Nutrition formula food applicable to tumor patient |
CN105056238A (en) * | 2015-09-22 | 2015-11-18 | 郑嘉雯 | Medicine composition with anti-tumor activity, as well as preparation method and application thereof |
CN105533696A (en) * | 2015-12-17 | 2016-05-04 | 北京振东光明药物研究院有限公司 | Powder type total-nutrient formula food for patients suffering from tumors |
CN106605908A (en) * | 2016-05-27 | 2017-05-03 | 韶关邦世迪健康实业有限公司 | Fully nutritional formula product with special medical purposes for liver diseases |
CN106890312A (en) * | 2015-12-18 | 2017-06-27 | 北京康爱营养科技股份有限公司 | A kind of Elental suitable for liver cancer patient and preparation method thereof |
CN107136509A (en) * | 2017-07-06 | 2017-09-08 | 北京爱博优营养科技有限公司 | It is a kind of to be used to improve functional food of immunity and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN108185437A (en) * | 2017-12-29 | 2018-06-22 | 北京康爱营养科技股份有限公司 | A kind of full nutrient formulation powder of tumour and preparation method thereof |
-
2018
- 2018-07-02 CN CN201810708141.7A patent/CN108991500A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101971939A (en) * | 2010-06-23 | 2011-02-16 | 安徽万山生物科技有限公司 | Process for making bee pollen freeze-dried powder through low-temperature high-pressure wall-breaking |
CN101971940A (en) * | 2010-06-23 | 2011-02-16 | 安徽万山生物科技有限公司 | Process for preparing low-temperature high-pressure wall-breaking pine pollen frozen powder capsule |
CN102526698A (en) * | 2012-01-05 | 2012-07-04 | 苟春虎 | Cordyceps polypeptide amino acid nutrient solution |
CN103330215A (en) * | 2013-07-11 | 2013-10-02 | 西安力邦临床营养有限公司 | Nutrition formula food applicable to tumor patient |
CN105056238A (en) * | 2015-09-22 | 2015-11-18 | 郑嘉雯 | Medicine composition with anti-tumor activity, as well as preparation method and application thereof |
CN105533696A (en) * | 2015-12-17 | 2016-05-04 | 北京振东光明药物研究院有限公司 | Powder type total-nutrient formula food for patients suffering from tumors |
CN106890312A (en) * | 2015-12-18 | 2017-06-27 | 北京康爱营养科技股份有限公司 | A kind of Elental suitable for liver cancer patient and preparation method thereof |
CN106605908A (en) * | 2016-05-27 | 2017-05-03 | 韶关邦世迪健康实业有限公司 | Fully nutritional formula product with special medical purposes for liver diseases |
CN107136509A (en) * | 2017-07-06 | 2017-09-08 | 北京爱博优营养科技有限公司 | It is a kind of to be used to improve functional food of immunity and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN108185437A (en) * | 2017-12-29 | 2018-06-22 | 北京康爱营养科技股份有限公司 | A kind of full nutrient formulation powder of tumour and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
吕百龄主编: "《实用工业助剂全书》", 31 August 2001, 化学工业出版社 * |
詹益兴主编: "《马尾松花粉与养生》", 30 September 2017, 科学技术文献出版社 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109805389A (en) * | 2019-02-26 | 2019-05-28 | 青岛大学附属医院 | A kind of tumour tailored version clinical nutrition formula and preparation method thereof |
CN109645484A (en) * | 2019-02-27 | 2019-04-19 | 王启荣 | A kind of nutritional formulas for senile chronic disease |
CN110150654A (en) * | 2019-06-21 | 2019-08-23 | 上海中优精准医疗科技股份有限公司 | A kind of special medicine purposes formula food for tumor patient |
CN110179107A (en) * | 2019-07-01 | 2019-08-30 | 北京东方倍力营养科技有限公司 | A kind of complete nutritional composition improving liver function and liver fibrosis |
CN110301629A (en) * | 2019-07-03 | 2019-10-08 | 安亦臣(武汉)健康科技有限公司 | A kind of full nutrient solid beverage of tumor patient and preparation method thereof |
CN110419727A (en) * | 2019-09-03 | 2019-11-08 | 生生源(大连)科技有限公司 | It effectively can prevent and improve the natural mineral matter replenishers of tumour |
CN110419728A (en) * | 2019-09-09 | 2019-11-08 | 山东禹泽医药科技有限公司 | A kind of tumour patient special medicine purposes full nutrition formula food |
CN110839803A (en) * | 2019-09-09 | 2020-02-28 | 付艳霞 | Total-nutrient meal replacement composition for treating tumor anorexia |
CN110916195A (en) * | 2019-11-25 | 2020-03-27 | 中国海洋大学 | Total nutrient tumor formula food added with specific marine oligopeptide and preparation method thereof |
CN112089051A (en) * | 2019-12-04 | 2020-12-18 | 上海张新生物医药科技有限公司 | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof |
CN112167614A (en) * | 2020-10-27 | 2021-01-05 | 袁希福 | A dietetic composition for postoperative treatment of tumor patients and radiotherapy and chemotherapy patients, and its preparation method |
CN113694179A (en) * | 2021-08-20 | 2021-11-26 | 安徽国肽生物科技有限公司 | Preparation method and application of ternary polypeptide nanoparticles based on yak bone peptide |
CN113694179B (en) * | 2021-08-20 | 2024-05-10 | 安徽国肽生物科技有限公司 | Preparation method and application of ternary polypeptide nano-particles based on yak bone peptide |
CN114868890A (en) * | 2022-03-26 | 2022-08-09 | 大医声科技(北京)有限公司 | Multi-vitamin nutrient formula suitable for tumor patients |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108991500A (en) | A kind of tumour patient full nutrition formula food | |
CN103005281B (en) | High-nutrient healthcare rice and preparation method thereof | |
CN101473953B (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
CN105211857B (en) | A kind of alimentation composition and application thereof | |
CN111011691A (en) | High-protein high-fiber solid beverage | |
CN108142803A (en) | Full nutrition coarse food grain | |
CN112089051A (en) | Nutritional composition for improving body inflammatory signs of tumor patients and preparation method thereof | |
CN106819793A (en) | A kind of instant class nutritional meal replacing food of quinoa | |
CN101695371A (en) | Health-care nutritive porridge | |
CN110771825A (en) | Comprehensive nutrition powder for reducing fat, blood sugar, blood pressure and blood fat and preparation method thereof | |
CN104605287A (en) | Branched chain amino acid containing aronia melanocarpa elliot food | |
JP2021524755A (en) | Hydrolyzed pea protein-based nutritional composition | |
CN108294306A (en) | A kind of full nutrition special medicine purposes formula food of amino acid pattern | |
CN108391811A (en) | A kind of tumour full nutrition formula food and its application | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN109380735A (en) | A kind of full nutritious food | |
CN105533688A (en) | Healthcare soft capsule with assistant blood-sugar reducing effect and preparation method thereof | |
CN104839695A (en) | Inflammatory bowel disease non-total nutrient formula food | |
CN108308597A (en) | A kind of malnutrition tailored version clinical nutrition formula and preparation method thereof | |
CN108782679A (en) | A kind of weight-reducing intervention is dry and preparation method thereof for refreshment | |
CN108713755A (en) | Quinoa weight reducing nutrition milk shake | |
WO2008140064A1 (en) | Nutrient composition for prevention and amelioration of lifestyle-related disease | |
CN110638038A (en) | Medical formula nutritional meal replacement powder for controlling hyperglycemia and preparation method thereof | |
CN104839699A (en) | Heart disease non-total nutrient formula food | |
CN104855992A (en) | Whole nutrient formula food for prostatic cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181214 |
|
RJ01 | Rejection of invention patent application after publication |